Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Bimosiamose 5% Cream for the Treatment of Patients With Chronic Plaque Type Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Bimosiamose (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000197-20).
- 11 May 2010 New trial record